To Be Precise | GenomeWeb

To Be Precise

Medical institutions across the US are investing in large centers, new technology, and more experts to bring precision medicine — the new personalized medicine — to the clinic, especially to cancer patients, the New York Times reports. While the expectation is that, eventually, every patient will undergo genomic sequencing, "even optimists warn that medicine is a long way from deriving useful information from routine sequencing," the Times says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Targeted to More

Seeking a Cohort

Down the Road a Ways

This Week in Science

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.